Another player involved in CD44v9-xCT complex stabilization is mucin 1 (MUC1) – a transmembrane glycoprotein commonly overexpressed in a plethora of cancers including lung, colon, breast, pancreatic and ovarian cancers (Chen et al., 2021; Figure 4A). This evidence concerns the gene MUC1 and cancer.